Skip to main content
. 2023 Dec 25;13(1):115. doi: 10.3390/jcm13010115

Table 1.

Baseline demographic, liver, and colorectal characteristics, perioperative and histological outcomes.

VIT D < 25 nmol/L (Total =12)
N (%)
VIT D ≥ 25 nmol/L (Total = 97)
N (%)
p Value
Age (liver surgery) 60 ± 11 66 ± 12 0.09
Gender 0.15
      Male 3 (25%) 44 (45.5%)
      Female 9 (75%) 53 (54.5%)
BMI 27.5 ± 3.6 26.4 ± 4.8 0.54
T 0.13
    1 1 (8.3%) 2 (2%)
    2 3 (25%) 6 (6.2%)
    3 6 (50%) 60 (61.8%)
    4 1(8.3%) 9 (9.3%)
    unknown 1 (8.3%) 20 (20.5%)
N 0.82
    N0 5 (41.7%) 32 (33%)
    N1 5 (41.7) 29 (29.9%)
    N2 1 (8.3%) 16 (16.5%)
    unknown 1 (8.3%) 20 (20.6%)
DFS (liver mets) 0.82
    <12 months 6 (50%) 51 (52.6%)
    ≥12 months 5 (41.7%) 37 (38.1%)
    unknown 1 (8.3%) 9 (9.3%)
Clinical risk factor (Fong) 0.59
  0–2 8 (66.7%) 67 (69.1%)
  3–5 3 (25%) 17 (17.5%)
Unknown 1 (8.3%) 13 (13.4%)
Size of largest liver tumor 0.37
    <5 cm 10 (83.3%) 85 (87.6%)
    ≥5 cm 2 (16.7%) 8 (8.2%)
    Unknown 4 (4.2%)
Number of liver metastases 0.75
  1 7 (58.3%) 57 (58.8%)
  >1 5 (41.7%) 40 (41.2%)
Peri-operative chemotherapy 0.92
  Yes 9 (75%) 71 (73.2%)
  No 3 (25%) 26 (26.8%)
Blood transfusion 0.011
    Yes 4 (33.3%) 10 (10.3%)
    No 5 (41.7%) 72 (74.2%)
    Unknown 3 (25%) 15 (15.5%)
Liver resection 0.17
    Anatomic 3 (25%) 12 (12.4%)
    Non-anatomic 9 (75%) 85 (87.6%)
Sequence of resection 0.97
    Liver first 1 (8.3%) 9 (9.3%)
    Colon first 9 (75%) 72 (72.2%)
    Combined 2 (16.7%) 18 (18.6%)
Complication: total 0.009
    Yes 6 (50%) 17 (17.5%)
    No 6 (50%) 19 (82.5%)
Complication: infection 0.04
    Yes 3 (25%) 7 (7.2%)
    No 9 (75%) 90 (92.8%)